Johnson & Johnson outlines contact lenses strategy

Johnson & Johnson outlines contact lenses strategy

Pharmaceutical company Johnson & Johnson has outlined a strategy for the rollout of contact lenses across the world in its latest report.

The company reviewed its growth strategies for its medical devices and diagnostics division at a meeting with the investment community yesterday (June 8th), where it also highlighted how the division generated $23.6 billion (£16.4 billion in sales in 2009 and became its largest business segment.

Alex Gorsky, worldwide chairman of Johnson & Johnson"s medical devices and diagnostics division, commented: "Thanks to the hard work of thousands of talented associates, we are the largest and strongest medical device company in the world today, and poised to continue advancing patient care in the future."

Last month, the company announced that its new 1 Day Acuvue Moist for Astigmatism will offer the "widest power range" of any daily disposable for astigmatism currently on the market, as they have accelerated stabilisation design, which provides patients with "clear and stable vision" throughout the day.

by Adrian Galbreth

« Back to list